CVX vs EYPT · P/E 17, rev $118.66B vs rev $1.2M
Chevron Corp (CVX) versus Eyepoint Pharmaceuticals Inc (EYPT) — a side-by-side from cached financials, not a winner call.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Mike Wirth.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
CVX currently screens at market cap $250.20B and trailing P/E 16.5. EYPT currently screens at market cap $1.10B.
Not investment advice. Open the CVX and EYPT stock pages for the full models.
Not investment advice.